Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,766 public trials 495 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Active, Not Recruiting

High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma

NCT00003641

Conditions
Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
  • Hembree Mercy Cancer Center at St. Edward Mercy Medical Center Fort Smith, Arkansas, United States
View all 533 locations
View Trial Details
Active, Not Recruiting

Effectiveness and Safety of Dabrafenib in Combination With Trametinib as Adjuvant Treatment for Chinese Patients With Stage III BRAF V600 Mutation-positive Melanoma After Complete Resection

NCT04666272

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Novartis Investigative Site Fuzhou, Fujian, China
  • Novartis Investigative Site Zhengzhou, Henan, China
  • Novartis Investigative Site Wuhan, Hubei, China
  • Novartis Investigative Site Changsha, Hunan, China
View Trial Details
Active, Not Recruiting

A Study of Tumor Imaging With Multispectral Optoacoustic Tomography

NCT05488483

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +12 more
Locations
  • Memorial Sloan Kettering Bergen (Consent only ) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent only) Commack, New York, United States
  • Memorial Sloan - Kettering Cancer Center New York, United States
  • Helmholtz Institute (Data Analysis Only) Munich, Germany
View Trial Details
Active, Not Recruiting

IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma

NCT05987332

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +15 more
Locations
  • Honor Health Scottsdale, Arizona, United States
  • Moores Cancer Center La Jolla, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
View all 68 locations
View Trial Details
Active, Not Recruiting

Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)

NCT03767348

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
Locations
  • University of Birmingham Alabama Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • Carti Cancer Center Little Rock, Arkansas, United States
View all 51 locations
View Trial Details

Related conditions